Condition: Diabetic Foot Ulcer · DFU · Diabetic Foot Ulcer (DFU) · Sponsor: Sequence LifeScience, Inc.
The goal of this study is to determine the between-arm difference in the proportion of subjects achieving complete closure of nonhealing diabetic foot ulcers with multiple CAMPs plus SOC versus matched controls over 12 weeks using a modified platform trial design.
This description comes directly from the study's public registry record.
Bennett Sarver · 1-833-865-6300 · info@serenagroups.com
Thomas Serena, MD · 1-833-865-6300 · info@serenagroups.com
Always discuss trial participation with your own doctor first.
| Serena Group- Monroeville | Monroeville, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07086443